Alpha-Rich Ideas
The Comedy Of Commvault
by Akram's Razor
Editor's notes: CVLT's slowing growth belies its post-earnings spike. Portfolio manager Akram's Razor dissects the conference call and says the stock should be trading at least 20% lower.
Breaking Alpha-Rich Articles (for Pro Subscribers. Learn more»)
This Energy Company Has 150%+ Upside by Tristan R. Brown
Tailwinds Galore For This Company In 2014: 50% Potential Upside by Josh Burwick
Gun Company: Analysis And Management Meeting Imply 100% Upside Potential by Nitin B. Sharma
The Comedy Of Commvault by Akram's Razor
Long Ideas
Shell Oil Stubs Its Big Toe by Ray Merola
Coca-Cola: The Pop Isn't Going To Fizz Away Anytime Soon by Investor Aide
Why Yelp Is Still By Far Undervalued by Scott Ryan
Cadence: Ofirmev Sales Are Very Strong; Patent Decision Could Come By Year-End by Smith On Stocks
LinkedIn: New Highs As Shorts Have Riskiest Position by The Value Investor
Your Portfolio Can Take Flight With Air Methods by Timing Best Buy
ECOtality: Simply A Great Investment by Way Of The Future
OEMs Are Killing The PC Industry by Justin Jaynes
Western Union: An Excellent Value Play For A Long-Term Investor by Netwall
Attunity Remains On Track To Triple by Mark Gomes
Skullcandy: Not Dead Yet by Insightful Investing
Zynga: The Market Got It Wrong by R.J. Chopin
Why I Think Broadcom Is A Clear Buy by Bottom Up Investing
Betting On Canterbury Park Holding by Tim Paul
Western Digital Remains A Quality Value Opportunity by Independent Value
The 'Retire Young Portfolio' Gets A Boost From SodaStream by Jacob Steinberg
Questcor Going Up Even After Earnings by Kraken
Hitting The Dislike Button For Facebook's Valuation by Marshall Hargrave
BBCN Bancorp: Profiting From A Growing Specialty Banking Niche by Todd Campbell
Cinedigm: A Hidden Digital Cinema Leader by Paulo Santos
Still Potential For Gains On Dell With Buyout Imminent by Quoth the Raven
Swift Energy: A Beat Up Company With Large Upside Potential by Fund Gurus
BioCryst: The Next Orphan Drug $1B+ Company by LifeSci Advisors
Grand Canyon University: Time To Invest In America's First For-Profit Division I University by Troy Bayer
Arena Sales Pace - Week 7 by Spencer Osborne
Biogen Idec Product Pipeline Will Propel It Higher by William Meyers
It's Time To Buy This Iconic American Stock by StreetAuthority
Tidewater Inc.: A Long-Term Buying Opportunity by Jeff Williams
I Remain Bullish On King Coal by Equity Watch
Kadant Is Undervalued With Multiple Value Catalysts by John Leonard
Reading International: An Asset Play First, Earnings Play Second by Mike Arnold
A Thinly-Traded Cyclical Turnaround With Further Upside by Brian Grosso
OmniVision Technologies - Looking At The Big 'Picture' And Diversifying Away From Apple by AlphaStreetResearch
The Buckle: 6% Yielding Retailer With Growth Prospects by Josh Arnold
Altria Offers An Attractive Investment Opportunity by Equity Watch
Why An Apple/China Mobile Deal Is Imminent by Skomes
Apple's Plastic 4 Inch iPhone 5C Has Lots Of Hidden Value by Keep It Simple
Vantage Drilling: A Young And Growing Offshore Drilling Outfit, But Debt Increases Risk by Power Hedge
Promising Opportunities With Major Customers For ChipMOS by Jaret Wilson
Why Speculative Investors Can't Ignore Advanced Cell Technology by Michael J. Ray
Hennes & Mauritz: Retailer's Growth In United States Worth Investing In by Chris Katje
Innovative KaloBios Pharmacuticals Could Be A Lucrative Buy by C.R. Jackson
Algoma Central: Ships And Bricks by Safety In Value
Dreamworks Animation: Diversification Puts Company On The Right Track To Long-Term Success by Chris Katje
A West African Gold Mining 'Endeavour' by Itinerant
New England Realty Associates: 50% Appreciation Potential To Fair Value by Nat Stewart
Implant Sciences: Sometimes Facts Lie by Sully
Intel: This Is Your Last Chance To Buy by Ashraf Eassa
Air Products And Chemicals: This Hedge Fund Manager's Best Deal Yet by Alex Cho
Entropic: Are Profits Delayed... Or Disappearing? by Vince Martin
Alaska Communications: The Finest Telecom Turnaround Of The Past Decade by Harry Long
Strayer Shines In The For-Profit Black Hole by Saj Karsan
Short Ideas
Tuesday Morning - One Of The Better Short Opportunities Out There by Geppe
Quick Picks & Lists
Off To The Races With Extraordinary Biotech And Medtech Companies: Jason Napodano by Life Sciences Report
Do The Fertilizer Stocks Really Stink As Bad As The Market Thinks? by Henry Stokman
Which Cell Carrier Will Win Your Upgrade? by Kevin Greenhalgh
These Companies Are Scrambling To Buy Back $20 Billion In Stock by StreetAuthority
July 2013 Car Sales: A Case Of Case-Shiller? by TheCarConnection
What Robert Downey Jr. Can Teach Us About Dell; The9 Underwhelms by Charles Zhang
Deferred Tax Assets And Liabilities by David Trainer
Yeah Yelp - Fresh Highs As Growth Continues And Losses Diminish by The Value Investor
Bear Of The Day: Rentech by Zacks Investment Research
Bull Of The Day: Alliance Fiber Optic by Zacks Investment Research
Industry Impacts From Student Loan Legislation by Bill Francis
Substantial Value Potential In Recently Underperforming Biotechs by Brian L. Wilson
No Need To Pray For Yield With 'Fallen Angels' by Dividends & Income Daily
5 Natural Gas Transportation Stocks For 2013: July Update by Michael Fitzsimmons
Should You Play These Turnaround Candidates? by Emerging Growth
Getting Rigged Up For Deep Sea Dividends by Dividends & Income Daily
Insider Ownership
Is It Time To Buy Freeport-McMoRan? 2 Insiders Just Paid Over $42.8 Million by Little Apple
Facebook, LinkedIn: Recent Intensive Insider Selling by Markus Aarnio
Insiders Are Buying Hansen Medical by Markus Aarnio
IPO Analysis
Sprouts Pops 123% In Market Debut, Best First-Day Return Since March 2011 by Renaissance Capital IPO Research
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario